BridgeMD
New treatment option for Breast Cancer
Official title Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
ClinicalTrials.gov ID: NCT06855654
What this study is testing
- What it's testing
- This pilot interventional study evaluates the change from baseline to post-intervention in resilience and other patient-reported outcomes for individuals with a recent diagnosis of metastatic breast cancer (MBC) participating in the Promoting Resilience in Women with Breast Cancer (PRISM) intervention, overall and stratified by race, and to evaluate the feasibility and acceptability of the PRISM intervention in the MBC population. Black women with MBC have shorter survival from the time of metastatic diagnosis to death, compared to White women with clinically similar disease, and may have more rapid declines in quality of life over time.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
- Participants are willing and able to comply with study procedures based on the judgement of the investigator.
- Male and female patients of age \>18 years.
- Pathologic diagnosis of metastatic breast cancer within 182 days prior to enrollment date.
- Able to answer surveys and participate in counseling sessions in English (the patient's first language is not required to be English).
You likely can't join if
- Individuals meeting any of the following exclusion criteria will be excluded from study participation.
- Patient unwilling or unable to complete surveys via one of the following methods: (a) paper survey completed in clinic or mailed directly to...
- Patient unwilling or unable to provide verbal or signed consent to participate.
- Participant cannot read English.
- Patient has permanently discontinued cancer-directed therapy or does not intend to receive any cancer-directed therapy, is receiving home or...
See the full eligibility criteria
- Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
- Participants are willing and able to comply with study procedures based on the judgement of the investigator.
- Male and female patients of age \>18 years.
- Pathologic diagnosis of metastatic breast cancer within 182 days prior to enrollment date.
- Able to answer surveys and participate in counseling sessions in English (the patient's first language is not required to be English).
- Indicate intent to receive ongoing cancer care at the enrolling institution.
- Individuals meeting any of the following exclusion criteria will be excluded from study participation.
- Patient unwilling or unable to complete surveys via one of the following methods: (a) paper survey completed in clinic or mailed directly to patient's home address, including a pre-addressed, pre-stamped return envelope...
- Patient unwilling or unable to provide verbal or signed consent to participate.
- Participant cannot read English.
- Patient has permanently discontinued cancer-directed therapy or does not intend to receive any cancer-directed therapy, is receiving home or residential hospice care, is hospitalized, or is described as likely to die...
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
- Chapel Hill, North Carolina, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States; Chapel Hill, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.